BACKGROUND
Adoption of step therapy (ST) is quickly outpacing the market's understanding of its clinical, humanistic, and economic outcomes. The broad scope of previous reviews of drug management programs has prohibited an in-depth discussion of the ST literature specifically.
OBJECTIVE
To conduct a critical review of ST program evaluations, discuss their policy implications, and provide reco...
